{"id":"https://openalex.org/W4396803113","doi":"https://doi.org/10.1097/cco.0000000000001041","title":"State of the art and upcoming trends in claudin-directed therapies in gastrointestinal malignancies","display_name":"State of the art and upcoming trends in claudin-directed therapies in gastrointestinal malignancies","publication_year":2024,"publication_date":"2024-04-23","ids":{"openalex":"https://openalex.org/W4396803113","doi":"https://doi.org/10.1097/cco.0000000000001041","pmid":"https://pubmed.ncbi.nlm.nih.gov/38726797"},"language":"en","primary_location":{"id":"doi:10.1097/cco.0000000000001041","doi":"https://doi.org/10.1097/cco.0000000000001041","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cco.0000000000001041","pdf_url":null,"source":{"id":"https://openalex.org/S179395531","display_name":"Current Opinion in Oncology","issn_l":"1040-8746","issn":["1040-8746","1080-8140","1531-703X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013187820","display_name":"Jane Elizabeth Rogers","orcid":"https://orcid.org/0000-0002-7275-7008","observed_orcids":["https://orcid.org/0000-0002-7275-7008"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jane E. Rogers","raw_affiliation_strings":["U.T. M.D. Anderson Cancer Center Pharmacy Clinical Programs"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.T. M.D. Anderson Cancer Center Pharmacy Clinical Programs","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044064524","display_name":"Jaffer A. Ajani","orcid":"https://orcid.org/0000-0001-9946-0629","observed_orcids":["https://orcid.org/0000-0001-9946-0629"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jaffer A. Ajani","raw_affiliation_strings":["U.T. U.T. M.D. Anderson Cancer Center Department of Gastrointestinal Medical Oncology, Houston, Texas, USA","fax: +713 563 9192","to Jaffer A. Ajani, MD, U.T. M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. Tel: +1 713 792 2828"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.T. U.T. M.D. Anderson Cancer Center Department of Gastrointestinal Medical Oncology, Houston, Texas, USA","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"fax: +713 563 9192","institution_ids":[]},{"raw_affiliation_string":"to Jaffer A. Ajani, MD, U.T. M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. Tel: +1 713 792 2828","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5044064524"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":1.1613,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.77813298,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"36","issue":"4","first_page":"308","last_page":"312"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/claudin-18-2","display_name":"claudin 18.2","score":0.953000009059906},{"id":"https://openalex.org/keywords/zolbetuximab","display_name":"zolbetuximab","score":0.8870000243186951},{"id":"https://openalex.org/keywords/gastric-adenocarcinoma","display_name":"gastric adenocarcinoma","score":0.9580000042915344},{"id":"https://openalex.org/keywords/gastrointestinal-cancer","display_name":"gastrointestinal cancer","score":0.9350000023841858},{"id":"https://openalex.org/keywords/tight-junctions","display_name":"tight junctions","score":0.8169999718666077},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8119999766349792},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.8349999785423279},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.9750000238418579},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":1.0},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.6700000166893005},{"id":"https://openalex.org/keywords/claudin-6","display_name":"CLDN6","score":0.847000002861023},{"id":"https://openalex.org/keywords/claudin-4","display_name":"claudin-4","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C51872919","wikidata":"https://www.wikidata.org/wiki/Q420863","display_name":"Claudin","level":3,"score":0.7041226029396057},{"id":"https://openalex.org/C48103436","wikidata":"https://www.wikidata.org/wiki/Q599031","display_name":"State (computer science)","level":2,"score":0.4851473271846771},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42790839076042175},{"id":"https://openalex.org/C3018574109","wikidata":"https://www.wikidata.org/wiki/Q329338","display_name":"State of art","level":2,"score":0.4121853709220886},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34100258350372314},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.22205299139022827},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22075051069259644},{"id":"https://openalex.org/C2522767166","wikidata":"https://www.wikidata.org/wiki/Q2374463","display_name":"Data science","level":1,"score":0.18052133917808533},{"id":"https://openalex.org/C177779419","wikidata":"https://www.wikidata.org/wiki/Q1053832","display_name":"Tight junction","level":2,"score":0.09731638431549072},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07710069417953491},{"id":"https://openalex.org/C11413529","wikidata":"https://www.wikidata.org/wiki/Q8366","display_name":"Algorithm","level":1,"score":0.052105993032455444}],"mesh":[{"descriptor_ui":"D005770","descriptor_name":"Gastrointestinal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005770","descriptor_name":"Gastrointestinal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005770","descriptor_name":"Gastrointestinal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005770","descriptor_name":"Gastrointestinal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005770","descriptor_name":"Gastrointestinal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057167","descriptor_name":"Claudins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D057167","descriptor_name":"Claudins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D057167","descriptor_name":"Claudins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D057167","descriptor_name":"Claudins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D057167","descriptor_name":"Claudins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D057167","descriptor_name":"Claudins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D057167","descriptor_name":"Claudins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D057167","descriptor_name":"Claudins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D057167","descriptor_name":"Claudins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/cco.0000000000001041","doi":"https://doi.org/10.1097/cco.0000000000001041","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cco.0000000000001041","pdf_url":null,"source":{"id":"https://openalex.org/S179395531","display_name":"Current Opinion in Oncology","issn_l":"1040-8746","issn":["1040-8746","1080-8140","1531-703X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Oncology","raw_type":"journal-article"},{"id":"pmid:38726797","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38726797","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8199999928474426}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1999130958","https://openalex.org/W2356237324","https://openalex.org/W2955746156","https://openalex.org/W3081634347","https://openalex.org/W3126113659","https://openalex.org/W3132443161","https://openalex.org/W3198165187","https://openalex.org/W4205225424","https://openalex.org/W4286295655","https://openalex.org/W4312187010","https://openalex.org/W4317892009","https://openalex.org/W4365813058","https://openalex.org/W4379283977","https://openalex.org/W4384522913","https://openalex.org/W4385429828","https://openalex.org/W4388011966","https://openalex.org/W4388464337","https://openalex.org/W4388729943","https://openalex.org/W4389439158","https://openalex.org/W4390946922","https://openalex.org/W4391090974","https://openalex.org/W6790210524","https://openalex.org/W6858079220","https://openalex.org/W6858154493"],"related_works":["https://openalex.org/W3024323633","https://openalex.org/W4390543751","https://openalex.org/W7172442542","https://openalex.org/W7124443840","https://openalex.org/W7165537434","https://openalex.org/W7155356323","https://openalex.org/W4392951961","https://openalex.org/W4408576112","https://openalex.org/W7118171347","https://openalex.org/W7166700583"],"abstract_inverted_index":{"PURPOSE":[0],"OF":[1],"REVIEW:":[2],"Claudins,":[3],"components":[4],"of":[5,72,100,109,134],"tight":[6],"cell":[7],"junctions":[8],"in":[9,20,58,67,96,120,138,146,168],"epithelial":[10],"and":[11,42,142,161],"endothelial":[12],"cells,":[13],"have":[14],"emerged":[15],"as":[16,45,125],"a":[17,31],"therapeutic":[18],"target":[19,95,103,158],"gastrointestinal":[21],"(GI)":[22],"malignancies,":[23],"particularly":[24],"claudin":[25,48,156,159],"18.2":[26],"(CLDN18.2).":[27],"RECENT":[28],"FINDINGS:":[29],"Zolbetuximab,":[30],"chimeric":[32],"anti-CLDN18.2":[33],"monoclonal":[34],"antibody":[35],"(mAb),":[36],"is":[37],"currently":[38],"under":[39,87,164],"FDA":[40],"review":[41],"may":[43],"emerge":[44],"the":[46,107,116,139],"first":[47],"targeted":[49],"therapy":[50],"approved.":[51],"Phase":[52],"3":[53],"trials":[54],"show":[55],"that":[56,151,157],"zolbetuximab":[57],"combination":[59],"with":[60],"front-line":[61],"fluoropyrimidine":[62],"plus":[63],"oxaliplatin":[64],"improves":[65],"survival":[66],"advanced":[68],"CLDN18.2":[69,90,104,135],"positive":[70],"(\u226575%":[71],"tumor":[73],"cells)":[74],"gastric":[75],"adenocarcinoma":[76],"(GAC)":[77],"patients.":[78],"Many":[79],"other":[80],"therapies":[81],"(mAbs;":[82],"CART;":[83],"bispecific;":[84],"ADCs)":[85],"are":[86,149,163],"investigation.":[88,165],"SUMMARY:":[89],"will":[91,114,171],"be":[92,115,129,173],"an":[93],"important":[94],"GAC.":[97],"Early":[98],"understanding":[99],"how":[101],"to":[102,118],"based":[105],"on":[106],"level":[108],"expression":[110],"(high,":[111],"moderate,":[112],"low)":[113],"key":[117],"success":[119],"this":[121],"area.":[122],"Studying":[123],"these":[124],"separate":[126],"entities":[127],"should":[128],"considered.":[130],"Resistance":[131],"patterns,":[132],"loss":[133],"expression,":[136],"role":[137,145,167],"refractory":[140],"setting,":[141],"if":[143],"any":[144],"localized":[147],"disease":[148],"questions":[150],"remain.":[152],"Other":[153],"targets":[154],"for":[155],"six":[160],"four":[162],"Their":[166],"GI":[169],"malignancies":[170],"soon":[172],"further":[174],"clarified.":[175]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2024-05-11T00:00:00"}